Abbott Offers Fixes To Clear $25B St. Jude Deal In EU
Abbott Laboratories has offered remedies to alleviate concerns that its $25 billion cash-and-stock acquisition of medical device maker St. Jude Medical will harm competition in the European Union, according to a filing submitted to the EU's antitrust watchdog.
/apple-touch-icon.png
Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

Daily newsletters

Expert analysis

Mobile app

Advanced search

Judge information

Real-time alerts

450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.

You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.

We take your privacy seriously. Please see our Privacy Policy.